focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Morgan Stanley cuts Wizz Air but upgrades easyJet

Mon, 12th Jul 2021 10:06

(Alliance News) - The following London-listed shares received analyst recommendations on Friday afternoon and Monday morning:

----------

FTSE 100

----------

UBS RAISES PERSIMMON PRICE TARGET TO 3,015 (2,915) PENCE - 'NEUTRAL'

----------

KEPLER CHEUVREUX CUTS VODAFONE PRICE TARGET TO 165 (170) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES RENISHAW PRICE TARGET TO 6,340 (6,300) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS SMITHS GROUP PRICE TARGET TO 1,880 (1,920) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES SPIRAX-SARCO PRICE TARGET TO 12,000 (11,400) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES JOHNSON MATTHEY TARGET TO 2,640 (2,540) PENCE - 'UNDERWEIGHT'

----------

BERENBERG RAISES NATWEST PRICE TARGET TO 240 (230) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES SCHRODERS PRICE TARGET TO 3,045 (2,960) PENCE - 'SELL'

----------

MORGAN STANLEY RAISES SCHRODERS TARGET TO 3,810 (3,760) PENCE - 'EQUAL-WEIGHT'

----------

BARCLAYS RAISES M&G PRICE TARGET TO 194 (192) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN SACHS CUTS STANDARD LIFE ABERDEEN PRICE TARGET TO 361 (376) PENCE - 'BUY'

----------

MORGAN STANLEY CUTS STANDARD LIFE ABERDEEN TARGET TO 305 (309) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES HARGREAVES LANSDOWN TARGET TO 1,573 (1,551) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS RAISES DIAGEO PRICE TARGET TO 3,940 (3,850) PENCE - 'OVERWEIGHT'

----------

RBC CUTS B&M PRICE TARGET TO 575 (580) PENCE - 'OUTPERFORM'

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 9,950 (8,850) PENCE - 'BUY'

----------

FTSE 250

----------

MORGAN STANLEY CUTS WIZZ AIR TO 'EQUAL-WEIGHT' (OVERWEIGHT) PRICE TARGET 4,900 (4,700) PENCE

----------

MORGAN STANLEY RAISES EASYJET TO 'OVERWEIGHT' (EQUAL-WEIGHT) - PRICE TARGET 1,100 (800) PENCE

----------

MORGAN STANLEY RAISES ASHMORE GROUP TARGET TO 446 (443) PENCE - 'EQUAL-WEIGHT'

----------

UBS RAISES REDROW PRICE TARGET TO 890 (810) PENCE - 'BUY'

----------

KEPLER CHEUVREUX RAISES CENTRICA PRICE TARGET TO 50 (40) PENCE - 'REDUCE'

----------

GOLDMAN SACHS RAISES CENTRICA PRICE TARGET TO 73 (69) PENCE - 'BUY'

----------

PEEL HUNT CUTS VECTURA GROUP PRICE TARGET TO 150 (155) PENCE - 'HOLD'

----------

RBC RAISES HAYS TO 'OUTPERFORM' (SECTOR PERFORM) - PRICE TARGET 195 (150) PENCE

----------

GOLDMAN SACHS RAISES MAN GROUP PRICE TARGET TO 200 (195) PENCE - 'NEUTRAL'

----------

MORGAN STANLEY RAISES MAN GROUP PRICE TARGET TO 245 (216) PENCE - 'OVERWEIGHT'

----------

SBC RAISES VICTREX PRICE TARGET TO 2,600 (2,450) PENCE

----------

UBS RAISES VICTREX PRICE TARGET TO 2200 (2100) PENCE - 'SELL'

----------

BARCLAYS CUTS MEGGITT PRICE TARGET TO 491 (533) PENCE - 'OVERWEIGHT'

----------

RBC RAISES PAGEGROUP TO 'OUTPERFORM' (SECTOR PERFORM) - PRICE TARGET 700 (525) PENCE

----------

GOLDMAN SACHS RAISES SPECTRIS PRICE TARGET TO 2,620 (2,610) PENCE - 'SELL'

----------

GOLDMAN SACHS RAISES PENNON GROUP PRICE TARGET TO 1,106 (1,084) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES ELECTROCOMPONENTS TARGET TO 935 (900) PENCE - 'EQUAL WEIGHT'

----------

UBS RAISES MORRISON SUPERMARKETS PRICE TARGET TO 254 (190) PENCE - 'NEUTRAL'

----------

HSBC RAISES WH SMITH PRICE TARGET TO 2,190 (2,170) PENCE - 'BUY'

----------

JEFFERIES RAISES AO WORLD TO 'BUY' ('HOLD') - TARGET 400 PENCE

----------

OTHER MAIN MARKET AND AIM

----------

MORGAN STANLEY RAISES RYANAIR PRICE TARGET TO 20 (17) EUR - 'OVERWEIGHT'

----------

BARCLAYS CUTS IQE PRICE TARGET TO 57 (70) PENCE - 'EQUAL WEIGHT'

----------

PEEL HUNT INITIATES GLOBALDATA WITH 'HOLD' - TARGET 1,400 PENCE

----------

BERENBERG RAISES SENIOR PLC PRICE TARGET TO 170 (112) PENCE - 'HOLD'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.